Feasibility of a Traceback Approach for Using Pathology Specimens to Facilitate Genetic Testing in the Genetic Risk Analysis in Ovarian Cancer (GRACE) Study Protocol

Guidelines currently state that genetic testing is clinically indicated for all individuals diagnosed with ovarian cancer. Individuals with a prior diagnosis of ovarian cancer who have not received genetic testing represent missed opportunities to identify individuals with inherited high-risk cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Kauffman, Tia L., Prado, Yolanda K., Reyes, Ana A., Zepp, Jamilyn M., Sawyer, Jennifer, White, Larissa Lee, Martucci, Jessica, Salas, Suzanne Bianca, Vertrees, Sarah, Rope, Alan F., Weinmann, Sheila, Henrikson, Nora B., Lee, Sandra Soo-Jin, Feigelson, Heather Spencer, Hunter, Jessica Ezzell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625870/
https://www.ncbi.nlm.nih.gov/pubmed/34834546
http://dx.doi.org/10.3390/jpm11111194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625870/
https://www.ncbi.nlm.nih.gov/pubmed/34834546
http://dx.doi.org/10.3390/jpm11111194

Ejemplares similares